top of page



June 1, 2023

Francisco Orellana, a seasoned professional who has worked in the biotech sector for over twenty years, joined Exciva as Chief Financial Officer.

December 1, 2022

Nadine Knowles joined the Exciva team as Head of Clinical Operations. She has over thirty years of experience in operationalising clinical trials, with particular expertise in clinical studies focussing on agitation in Alzheimer's disease dementia, gained from her leadership roles at Avanir and Otsuka.


October 25, 2022

The US PTO granted a patent to Exciva for its invention of innovative composition of matter with various therapeutic uses in neuropsychiatry

October 11, 2022

Exciva successfully completed Phase I study of its proprietary EXV-802 combination of dextromethorphan and a 5-HT2A/2C receptor inverse agonist

July 1, 2022

Dr Jina Swartz joined Exciva as Chief Medical Officer bringing with her over twenty years of experience in Neuroscience global clinical development and translational medicine

October 26, 2021

Exciva raises €9 million in Series A round led by Andera Partners (full press release)

bottom of page